Hubei Goto Biopharm Group Co., Ltd. (SHE:300966)
China · Delayed Price · Currency is CNY 24.85
+0.10 (0.40%)
Nov 5, 2026, 3:04 PM CST
Hubei Goto Biopharm Group Market Cap
Hubei Goto Biopharm Group has a market cap or net worth of 2.84 billion as of November 5, 2026. It is the 15,478th most valuable company in the world and the 4,178th biggest in China. Its market cap has increased by 9.07% in one year.
Market Cap
2.84B
Enterprise Value
4.17B
Revenue
665.71M
Global Rank
Country Rank
#4,178 China
PE Ratio
n/a
ChartMarket Cap Chart
Since April 9, 2021, Hubei Goto Biopharm Group's market cap has decreased from 6.57B to 2.84B, a decrease of -56.80%. That is a compound annual growth rate of -13.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 2.84B | 25.25% |
| Dec 31, 2025 | 2.27B | 21.86% |
| Dec 31, 2024 | 1.86B | -29.78% |
| Dec 29, 2023 | 2.65B | -14.93% |
| Dec 30, 2022 | 3.11B | -34.18% |
| Dec 31, 2021 | 4.73B | -28.02% |
| Apr 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Qingdao Vland Biotech INC. | 3.02B |
| Shanghai Shen Lian Biomedical | 3.01B |
| Xiangxue Pharmaceutical | 2.94B |
| Jiangsu Bioperfectus Technologies | 2.92B |
| Lifecome Biochemistry | 2.89B |
| Guanhao Biotech | 2.88B |
| Zhejiang Shouxiangu Pharmaceutical | 2.74B |
| Beijing Kawin Technology Share-Holding | 2.71B |